Phase 1 Trial of Tucatinib, Trastuzumab, and Capecitabine With Stereotactic Radiosurgery in Patients With Brain Metastases From HER-2 Positive Breast Cancer

Manmeet Ahluwalia, Miami Cancer Institute
Atulya Khosla, Miami Cancer Institute
Ahmad Ozair, Miami Cancer Institute
Rupesh Kotecha, Miami Cancer Institute
Michael McDermott, Miami Neuroscience Institute
Minesh Mehta, Miami Cancer Institute

Abstract